Doijiri, Ryosuke
Ueno, Yuji
Kikuno, Muneaki
Shimizu, Takahiro
Tateishi, Yohei
Kuriki, Ayako
Takekawa, Hidehiro
Shimada, Yoshiaki
Kanemaru, Kodai
Kamiya, Yuki
Yamaguchi, Eriko
Koga, Masatoshi
Ihara, Masafumi
Tsujino, Akira
Hirata, Koichi
Hasegawa, Yasuhiro
Kikuchi, Takahiko
Hattori, Nobutaka
Urabe, Takao
Article History
Received: 18 December 2020
Accepted: 17 March 2021
First Online: 29 March 2021
Competing interests
: Y.U received lecture fees from OHARA Pharmaceutical Co., Ltd. and research funds from Bristol-Myers Squibb. H.T received lecture fees from Pfizer Japan Inc. and Daiichi Sankyo Co., Ltd. M.K received lecture fees from Bayer Pharmaceutical Co., M.I received a research grant from Shimadzu Corporation, Otsuka Pharmaceutical, and Panasonic Corporation, and lecture fees from Daiichi Sankyo Co., Ltd, Eisai Co. Ltd. Bayer Pharmaceutical Co. K.H received lecture fees from MSD Co., Ltd., Eisai Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Pfizer Japan Inc., Novartis Pharma K.K., and AbbVie GK, and research funds from Eisai Co., Ltd., Pfizer Japan Inc., Novartis Pharma K.K., Takeda Pharmaceutical Co., Ltd., TAIYO Co., Ltd., Kyowa Minami Hospital, Shirasawa Hospital, Shiobara Onsen Hospital, Utsunomiya Chuo Hospital, Nishikata Hospital, and Moka Hospital. Y.H received lecture fees from Bayer Pharmaceutical Co., N.H was an advisory member of Dai-Nippon Sumitomo Pharma Co., Ltd., Hisamitsu Pharmaceutical Co., Inc, Biogen Idec Japan Ltd., received lecture fees from Dai-Nippon Sumitomo Pharma Co., Ltd., Otsuka Pharmaceutical, Co., Ltd., Takeda Pharmaceutical Co., Ltd., Kyowa Hakko-Kirin Co., Ltd., FP Pharmaceutical Corporation, Eisai Co., Ltd., Novartis Pharma K.K., and AbbVie, and received departmental endowments by commercial entities from Kyowa Hakko-Kirin Co., Ltd., Nippon Boehringer Ingelheim, Co., Ltd., AbbVie GK, FP Pharmaceutical Corporation, Otsuka Pharmaceutical, Co., Ltd., Dai-Nippon Sumitomo Pharma Co., Ltd., Eisai Co., Ltd., Nihon Medi-physics Co., Ltd., Asahi Kasei Medical Co., Ltd., Ono Pharmaceutical Co., Ltd., MiZ Co., Ltd., AbbVie GK, OHARA Pharmaceutical Co., Ltd., Nihon Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Boston Scientific Corporation, and Medtronic Inc. T.U received lecture fees from Daiichi Sankyo Co., Ltd., Boehringer Ingelheim, Otsuka Pharmaceutical Co., Ltd., Bayer Pharmaceutical Co., AstraZeneca K.K., and AbbVie GK., and research funds from Otsuka Pharmaceutical Co., Ltd., Astellas Pharma Inc., Bayer Pharmaceutical Co. Ltd., AbbVie GK, and Eisai Co., Ltd. Other authors have no conflicts of interests.